|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 49, 410-419, February 2008 Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome
* Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE Published, JLR Papers in Press, October 30, 2007.
1 To whom correspondence should be addressed. e-mail: wrizzo{at}unmc.edu Sjögren-Larsson syndrome (SLS) is an inherited neurocutaneous disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH). FALDH is an enzyme component of fatty alcohol:NAD oxidoreductase (FAO), which is necessary for fatty alcohol metabolism. To better understand the biochemical basis for the cutaneous symptoms in this disease, we investigated lipid metabolism in cultured keratinocytes from SLS patients. Enzyme activities of FALDH and FAO in SLS cells were <10% of normal. SLS keratinocytes accumulated 45-fold more fatty alcohol (hexadecanol, octadecanol, and octadecenol) than normal, whereas wax esters and 1-O-alkyl-2,3-diacylglycerols were increased by 5.6-fold and 7.5-fold, respectively. SLS keratinocytes showed a reduced incorporation of radioactive octadecanol into fatty acid (24% of normal) and triglyceride (13% of normal), but incorporation into wax esters and 1-O-alkyl-2,3-diacylglycerol was increased by 2.5-fold and 2.8-fold, respectively. Our results indicate that FALDH deficiency in SLS keratinocytes causes the accumulation and diversion of fatty alcohol into alternative biosynthetic pathways. The striking lipid abnormalities in cultured SLS keratinocytes are distinct from those seen in fibroblasts and may be related to the stratum corneum dysfunction and ichthyosis in SLS.
Supplementary key words aldehyde dehydrogenase alkylglycerol epidermis ether glycerolipid fatty aldehyde ichthyosis mental retardation plasmalogen stratum corneum wax ester Abbreviations: CH2Cl2, dichloromethane; DMA, dimethyl acetal; FALDH, fatty aldehyde dehydrogenase; FAO, fatty alcohol:NAD oxidoreductase; HPTLC, high-performance thin-layer chromatography; LTB4, leukotriene B4; N-alkyl-PE, N-alkyl-phosphatidylethanolamine; PKC, protein kinase C; SC, stratum corneum; SLS, Sjögren-Larsson syndrome; 16:0-OH, hexadecanol; 18:0-OH, octadecanol; 18:1-OH, octadecenol; 22:0-OH, behenyl alcohol
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||